Obstructive Sleep Apnea: Clinical Trials

29 trials for Obstructive Sleep Apnea, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

29 completed. 29 Phase 3, 5 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 329Completed 29
Phase 25Completed 5

Follow Obstructive Sleep Apnea: new trials by email Literature Review of Obstructive Sleep Apnea trials Research Report on Obstructive Sleep Apnea

Trials (filtered) newest first · largest first

All 29 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
RePOSA-Revealing the Efficacy of IHL-42X Use in Patients With OSA
IHL-42X Low Dose, IHL-42X High Dose, Placebo - Obstructive Sleep Apnea
Phase 2 / Phase 3CompletedIncannex Healthcare Ltd1212024-05-022026-07-27
A Study of Retatrutide (LY3437943) in Participants With Type 2 Diabetes Mellitus Who Have Obesity or Overweight
Retatrutide, Placebo - Type 2 Diabetes, Obesity
Phase 3CompletedEli Lilly and Company11522023-07-112026-07-30
A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight
Retatrutide, Placebo - Obesity, Overweight
Phase 3CompletedEli Lilly and Company23352023-07-102026-08-21
Dexamethasone Treatment for OSA in Children
Dexamethasone, Placebo Control - Obstructive Sleep Apnea
Phase 3CompletedThe Hospital for Sick Children102022-10-262026-05-12
Obstructive Sleep Apnea Master Protocol GPIF: A Study of Tirzepatide (LY3298176) in Participants With Obstructive Sleep Apnea
Tirzepatide, Placebo - Obstructive Sleep Apnea, Obesity
Phase 3CompletedEli Lilly and Company4692022-06-212025-04-30
Vitamin D and SGLT-2 Inhibitor in CPAP-naive Obstructive Sleep Apnea
Dapagliflozin (Forxiga), Vitamin D3 ( Colecalciferol), Vitamin D3 plus Dapagliflozin - Obstructive Sleep Apnea
Phase 3CompletedUniversity Malaysia Sarawak1602022-06-082024-11-15
Pitolisant (BF2.649) in the Treatment of EDS in Patients With OSA
Pitolisant (BF2.649), Placebo - Excessive Daytime Sleepiness, Obstructive Sleep Apnea
Phase 3CompletedBioprojet3892016-04-012020-07-08
"Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"
JZP-110, Placebo oral tablet - Obstructive Sleep Apnea
Phase 3CompletedJazz Pharmaceuticals4762015-05-012019-07-23
"Six-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"
JZP-110 - Obstructive Sleep Apnea
Phase 3CompletedJazz Pharmaceuticals1742015-05-012019-09-09
"A Long-Term Safety Study of JZP-110 in the Treatment of Excessive Sleepiness in Subjects With Narcolepsy or OSA"
JZP-110 - Narcolepsy, Obstructive Sleep Apnea
Phase 3CompletedJazz Pharmaceuticals6452015-05-012019-06-25
Effect of Antihypertensive Agents Over Sleep Apnea
Diuretics, Calcium Channel Blockers - Hypertension, Obstructive Sleep Apnea
Phase 3CompletedHospital de Clinicas de Porto Alegre532014-12-012016-07-14
BF2.649 in Patients With OSA, Still Complaining of EDS and Refusing to be Treated by CPAP.
BF2.649, Placebo - Obstructive Sleep Apnea, Excessive Daytime Sleepiness
Phase 3CompletedBioprojet2682011-10-012015-01-21
BF2.649 in Patients With OSA and Treated by CPAP But Still Complaining of EDS
BF2.649, Placebo - Obstructive Sleep Apnea, Excessive Daytime Sleepiness
Phase 3CompletedBioprojet2442011-08-012015-01-21
Effect of Zopiclone on Compliance With Continuous Positive Airway Pressure in Obstructive Sleep Apnea
Placebo, Zopiclone - Obstructive Sleep Apnea
Phase 3CompletedOSR Medical Inc.2642011-05-012015-07-17
Montelukast and Inhaled Nasal Steroid Tx in Adult Obstructive Sleep Apnea (OSA)
budesonide and montelukast, Placebo - Obstructive Sleep Apnea
Phase 3CompletedRomaker & Associates342010-09-012018-12-03
Stimulation Therapy for Apnea Reduction (Www.theSTARtrial.Com)
Inspire Upper Airway Stimulation System - Obstructive Sleep Apnea
Phase 3CompletedInspire Medical Systems, Inc.9292010-07-012017-08-25
US Clinical Study of the Apnex Medical Hypoglossal Nerve Stimulation (HGNS) System to Treat Obstructive Sleep Apnea
HGNS Treatment - Obstructive Sleep Apnea
Phase 2 / Phase 3CompletedApnex Medical, Inc.202010-07-012015-04-15
Australian Clinical Study of the Apnex Medical HGNS System to Treat Obstructive Sleep Apnea
HGNS Treatment - Obstructive Sleep Apnea
Phase 2 / Phase 3CompletedApnex Medical, Inc.402009-03-012015-04-15
Diagnosis and Treatment of Sleep Apnea in Cerebrovascular Disease
CPAP Therapy for Newly Diagnosed Obstructive Sleep Apnea (OSA) - Obstructive Sleep Apnea, Stroke
Phase 2 / Phase 3CompletedVA Office of Research and Development2252008-12-232017-06-14
Effects of Continuous Positive Airway Pressure (CPAP) in Patients With Resistant Hypertension and Obstructive Sleep Apnea (OSA)
CPAP - Obstructive Sleep Apnea, Refractory Hypertension
Phase 3CompletedUniversity of Sao Paulo402008-10-012011-11-23

Showing 20 of 29. Sign in to see all of them.

Narrower conditions

Sleep Apnea, Obstructive (29)  ·  Sleep Apnea Syndromes (6)  ·  Disorders of Excessive Somnolence (5)  ·  Hypertension (4)  ·  Obesity (3)  ·  Overweight (2)  ·  Brain Ischemia (1)  ·  Communication Disorders (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  Ischemic Attack, Transient (1)  ·  Narcolepsy (1)  ·  Nasal Obstruction (1)  ·  Osteoarthritis, Knee (1)  ·  Sleep Initiation and Maintenance Disorders (1)  ·  Sleep Wake Disorders (1)

Broader conditions

Apnea (29)  ·  Dyssomnias (29)  ·  Nervous System Diseases (29)  ·  Respiration Disorders (29)  ·  Respiratory Tract Diseases (29)  ·  Sleep Disorders, Intrinsic (29)  ·  Sleep Wake Disorders (28)  ·  Sleep Apnea Syndromes (23)  ·  Mental Disorders (8)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Signs and Symptoms (5)  ·  Cardiovascular Diseases (4)  ·  Vascular Diseases (4)  ·  Body Weight (3)  ·  Nutrition Disorders (3)

Interventions

pitolisant (3)  ·  solriamfetol (3)  ·  Modafinil (2)  ·  retatrutide (2)  ·  Acetazolamide (1)  ·  Amiloride (1)  ·  Amlodipine (1)  ·  Budesonide (1)  ·  Calcium Channel Blockers (1)  ·  Chlorthalidone (1)  ·  Cholecalciferol (1)  ·  Dexamethasone (1)  ·  Dexmedetomidine (1)  ·  Diuretics (1)  ·  Dronabinol (1)

Sponsors

Bioprojet (3)  ·  Eli Lilly and Company (3)  ·  Jazz Pharmaceuticals (3)  ·  Apnex Medical, Inc. (2)  ·  Cephalon (2)  ·  Clayton Sleep Insititute (2)  ·  University of Sao Paulo (2)  ·  Hospital de Clinicas de Porto Alegre (1)  ·  Incannex Healthcare Ltd (1)  ·  Inspire Medical Systems, Inc. (1)  ·  Nykøbing Falster County Hospital (1)  ·  OSR Medical Inc. (1)  ·  Romaker & Associates (1)  ·  Stanford University (1)  ·  The Hospital for Sick Children (1)

Countries

United States (16)  ·  Brazil (6)  ·  France (6)  ·  Canada (5)  ·  Germany (5)  ·  Australia (3)  ·  Mexico (3)  ·  Netherlands (3)  ·  Finland (2)  ·  India (2)  ·  Puerto Rico (2)  ·  Romania (2)  ·  Spain (2)  ·  Argentina (1)  ·  Belgium (1)

Top investigators

Evelyne De Paillette, MD (2)  ·  Ann Romaker, MD (1)  ·  Anuradha Patel, MD (1)  ·  Barbara Capozzolo, MSc (1)  ·  Clete A. Kushida M.D., Ph.D. (1)  ·  Con Iber, MD (1)  ·  David Hillman, MD (1)  ·  Dawn M. Bravata, MD (1)  ·  Doug McEvoy, MD (1)  ·  Eric Kezirian, MD (1)  ·  Eric Powell, PhD (1)  ·  Fabio T Cichelero, MD (1)  ·  Flavio D Fuchs, MD, PhD (1)

Results publications

PMID 37979718, PMID 19234106, PMID 21885958, PMID 22043118, PMID 22334806, PMID 22334808, PMID 22968110, PMID 23598607, PMID 24382030, PMID 24401051, PMID 24458967, PMID 30471270, PMID 30521757, PMID 31383235, PMID 31691827, PMID 31917607, PMID 32353246, PMID 32970962, PMID 33121980, PMID 33179591, PMID 33226332, PMID 33295277, PMID 33394323, PMID 33631141, PMID 33647987, PMID 34283019, PMID 34606437, PMID 36084494, PMID 38547961, PMID 38781664, PMID 38912654, PMID 40055713, PMID 40774158, PMID 41135142, PMID 41540105, PMID 41793578, PMID 42166156, PMID 42412744, PMID 42675225, PMID 42774617, PMID 42810372, PMID 42814954

NIH funding

2023 (2), 2009 (1)